SaigonBao.com

Archive -Daily News

Biotechnology News

Biotechnology : 2017December27Wednesday

FSU biotech ops degree to focus on business, finance

Option Market Alert: Puma Biotechnology Inc Implied Price Swing Hits An Inflection Point

Buy the position in Healthcare Stock: Puma Biotechnology, Inc. (PBYI)

Ameriprise Financial Inc. Has $19.82 Million Stake in Puma Biotechnology Inc (PBYI)

Puma Biotechnology (PBYI) Reaches Active Mover List (-0.67%)

Atlantic Trust Group LLC Has $6.89 Million Position in iShares NASDAQ Biotechnology Index (IBB)

Teetering Stock- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) a Biotechnology Company

Ultrapro Biotechnology Proshares (UBIO) MA Levels Holding Above FAMA

Tale of the Ticker: Puma Biotechnology (PBYI) Moves -0.98% on Volume

Investors Will Be Taking a Second Look at Puma Biotechnology Inc (NYSE:PBYI) After Recent Moves

Genetic Engineering: 2017December27Wednesday

Elayne Clift: A salute to STEM women

10 Unconventional "History Books" That Will Change The Way You Think About Everything

FDA approves gene therapy to fix mutations that can lead to blindness

Medicare for life

An AI expert explains how robot-human offspring would work

Local startup to make biomaterials for new 'frontier in medicine'

Return On Investment: Mingus Union program helps city bolster work force

Genetically Engineered Insects Next For Agriculture?

Eugenics, euthanasia and Beast Folk: a future warning from the past

New lab-bred super corals could help avert global reef wipeout

Biotech Industry : 2017December27Wednesday

FSU biotech ops degree to focus on business, finance

2017 in Review: San Antonio biotech companies score big wins

3 Bold Biotech Predictions For 2018!

Biotech sector's challenge with academic research

A year of biotech news, visualized

Biotech VC scorecard: How the state's biggest firms fared in 2017

Array Biopharma Shows Rising Price Performance With Jump To 85 RS Rating

Will Mylan NV (NASDAQ:MYL) Continue To Underperform Its Industry?

Kmart settles 2008 lawsuit for $32.3 million payment

Editas Medicine Joins Elite Club Of Stocks With RS Ratings Over 90